Loan Note Conversion, Issue of Warrants & Equity

Kin Group Plc / Epic: KIN.L / Index: AIM

RNS ANNOUNCEMENT: The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

20 July 2017

KIN GROUP PLC ('KIN' OR 'THE COMPANY')

Conversion of £50,000 of Loan Notes, Issue of Warrants and Issue of Equity

Kin Group Plc (AIM: KIN.L), the AIM quoted digital wellness provider for corporate organisations, trading as Kin Wellness, hereby announces that on 19 July 2017 it received a notice of conversion in respect of £50,000 in nominal value of the Loan Notes ("Notes") which were issued to Belastock Capital L.P. ("Belastock").

Definitions used in this announcement are taken from the Company's announcements dated 15 May 2017 ("Notes Announcement") unless otherwise stated.

Conversion of Notes, Issue of Warrants and Issue of Equity

The £50,000 of Notes have been converted at the closing bid price for the Company's ordinary shares on 19 July 2017 being 0.05 pence per ordinary share ("Conversion") resulting in the issue of 100,000,000 new ordinary shares (the "Conversion Shares").

Under the terms of the Conversion the Company has also issued Belastock with a warrant over 100,000,000 new ordinary shares in the Company with an exercise price the lower of:-

1 90% of the lowest closing bid price for the Company's ordinary shares for the three consecutive trading days ending prior to service of the relevant exercise notice; or

2 0.0625 pence per share.

The terms of the Warrants are as stated in the Notes Announcement.

Application will be made for the admission of the Conversion Shares to trading on AIM once the suspension in trading in the Company's ordinary shares has been lifted. A further announcement regarding the timing of admission and subsequent total voting rights will be made at that time. On admission the Conversion Shares will rank pari passu in all respects with the Company's existing ordinary shares.

-Ends-

For further information visit www.kinwellness.com 

Contact: